Ditchcarbon
  • Customers
  1. Organizations
  2. Quanterix Corporation
Public Profile
Medical Device Manufacturing
US
updated 5 months ago

Quanterix Corporation

Company website

Quanterix Corporation, a pioneering force in the life sciences sector, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in the development of ultra-sensitive biomarker detection technologies, primarily serving the fields of neurology, oncology, and infectious diseases. Quanterix's flagship product, the Simoa® (Single Molecule Array) platform, offers unparalleled sensitivity and precision in measuring biomarkers, setting a new standard in diagnostics and research. This innovative technology enables researchers and clinicians to detect low-abundance proteins, facilitating breakthroughs in disease understanding and treatment. With a strong market position, Quanterix has achieved significant milestones, including partnerships with leading pharmaceutical companies and academic institutions. Their commitment to advancing precision medicine continues to drive their growth and influence in the industry.

DitchCarbon Score

How does Quanterix Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Quanterix Corporation's score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

46%

Let us know if this data was useful to you

Quanterix Corporation's reported carbon emissions

Quanterix Corporation, headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The absence of emissions data suggests that the company may not have established formal climate commitments or reduction strategies at this time. As a result, there are no specific figures to report regarding their Scope 1, 2, or 3 emissions. Additionally, there are no Science-Based Targets Initiative (SBTi) reduction targets or other climate pledges documented. In the context of the industry, it is essential for companies like Quanterix to develop and disclose their climate strategies to align with global sustainability goals and enhance transparency. Without concrete data or commitments, it remains unclear how Quanterix plans to address its carbon footprint or contribute to climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Quanterix Corporation's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Quanterix Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Quanterix Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

10x Genomics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

HTG Molecular Diagnostics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Olink Proteomics AB

SE
•
Research and development services (73)
Updated 7 days ago

cytena GmbH

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 7 days ago

Myriad RBM, Inc.

US
•
Other business services (74)
Updated 7 days ago

Nanostring Technologies

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250731.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy